静脉血栓塞栓症患者的直接口服抗凝剂:日常实践中的当前挑战
Polish archives of internal medicine
|January 15, 2026
概括
直接口服抗凝剂 (DOAC) 对静脉血栓塞栓症 (VTE) 有效,但在特殊人群中存在挑战. 优化新策略的遵守和意识是有效使用DOAC的关键.
科学领域:
- 药理学和治疗学 药理学和治疗学
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 直接口服抗凝剂 (DOAC) 已经彻底改变了静脉血栓塞栓症 (VTE) 治疗,原因是可预测的药理动力学和不需要常规监测.
- 尽管临床试验数据强,但DOACs在现实世界中的应用面临挑战,特别是在特定的患者群体中.
研究的目的:
- 审查目前关于在VTE患者中使用DOAC的证据.
- 突出临床实践中的挑战,包括特殊人群,坚持,出血和剂量.
- 综合有关DOAC实施新兴战略的信息.
主要方法:
- 在PubMed,MEDLINE和Cochrane数据库中进行了全面的文献搜索.
- 包括过去5年的同行评审文章,重点关注DOAC和VTE.
- 优先进行随机对照试验,元分析,系统审查和观察性研究.
主要成果:
- DOAC已被确立为一线VTE疗法,尽管在肥胖,严重功能障碍,癌症和异常血栓形成部位的患者中仍然存在挑战.
- 网络元分析显示,DOAC药物的疗效相似,apixaban被认为具有更好的出血概况.
- 患者的坚持是减少VTE复发的关键,逆转药物有助于管理出血事件.
结论:
- DOACs是VTE的护理标准,越来越多的现实数据支持其安全性和有效性.
- 为了在特殊人群中管理DOAC,需要进行个性化风险效益评估.
- 加强患者教育以提高患者的坚持和医疗服务提供者对剂量修改和逆转策略的认识,对于最佳的DOAC实施至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis IV: Nursing Management
202
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
202
Venous Thrombosis I: Introduction
375
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
375
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
294
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
294


